EUVIMEDEUVIMED entdecken
Crossref

Multifunctional Hydrogel Eye Drops for Synergistic Treatment of Ocular Inflammatory Disease

Xinyu Liu, Zhongxing Chen iD, Jieyi Bai, Xin Li, Xin Chen, Zheng Li, Hongxian Pan, Siheng Li, Qingyi Gao, Nan Zhao, Aodong Chen, Huilin Xu und 5 weitere

ACS Nano · 26.12.2023 · 17 (24) · 25377-25390

DOI: 10.1021/acsnano.3c08869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 27.10.2023. Verfasst von Xinyu Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University; Key Laboratory of Myopia, Chinese Academy of Medical Sciences; S…. Hauptthemen laut MEDLINE: Dexamethasone, Uveitis. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Shanghai Medical College, Fudan University, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uveitis is a complex ocular inflammatory disease with a multifactorial etiology that can result in blindness. Although corticosteroid eye drops are the primary treatment for anterior uveitis, their efficacy is limited by low bioavailability, adverse effects, and a narrow focus on inflammation. In this study, the multifunctional hydrogel eye drops (designated as DCFH) were developed by incorporating the anti-inflammatory agent dexamethasone (DSP) and reactive oxygen species (ROS) scavenger cerium-based metal-organic frameworks (Ce-MOFs) into thermosensitive triblock copolymer F127 for the synergistic treatment against uveitis. The resulting F127 eye drops offer a favorable alternative to ophthalmic solution due to its thermosensitivity, thixotropy, light transmittance, improved ocular bioavailability, and unexpected anti-inflammatory efficacy. Notably, the participation of nanoporous Ce-MOFs, functional drug carriers, not only reduces ROS level but also boosts the anti-inflammatory activity of DSP in vitro. Therapeutically, the multifunctional DCFH exhibits superior efficacy in treating endotoxin-induced uveitis by mitigating the ophthalmic inflammatory reaction, suppressing inflammatory cytokines (e.g., TNF-α, IL-6, and IL-17) and downregulating the expression of iNOS and NLPR3. This synergistic treatment provides a valuable and promising approach for the management of uveitis and other ocular inflammatory conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneUveitisHumansHydrogelsReactive Oxygen SpeciesOphthalmic SolutionsAnti-Inflammatory AgentsInflammationPolyethylenesPolypropylenes

Stichwörter der Autor:innen

hydrogel eye dropsmetal−organic frameworksnoninvasive drug deliveryreactive oxygen speciessynergistic treatmentuveitis

Substanzen

DexamethasoneHydrogelsReactive Oxygen SpeciesOphthalmic SolutionsAnti-Inflammatory AgentsUCON 50-HB-5100PolyethylenesPolypropylenes

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University; Key Laboratory of Myopia, Chinese Academy of Medical Sciences; Shanghai Research Center of Ophthalmology and Optometry, Shanghai 20003…
  • Department of Ophthalmology, Ordos Central Hospital, Ordos, Inner Mongolia 017000, P.R. China.
  • School of Ophthalmology and Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
  • School of Chemical Engineering, Northeast Electric Power University, Jilin 132000, P. R. China.

ORCID-Profile: Zhongxing Chen, Jinhai Huang

Förderung

  • Shanghai Medical College, Fudan University
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
  • National Natural Science Foundation of China
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission

Zitieren

APA

Liu, X., Chen, Z., Bai, J., Li, X., Chen, X., Li, Z., Pan, H., Li, S., Gao, Q., Zhao, N., Chen, A., Xu, H., Wen, Y., Du, L., Yang, M., Zhou, X., & Huang, J. (2023). Multifunctional Hydrogel Eye Drops for Synergistic Treatment of Ocular Inflammatory Disease. ACS Nano, 17(24), 25377-25390. https://doi.org/10.1021/acsnano.3c08869

Vancouver

Liu X, Chen Z, Bai J, Li X, Chen X, Li Z, et al. Multifunctional Hydrogel Eye Drops for Synergistic Treatment of Ocular Inflammatory Disease. ACS Nano. 2023;17(24):25377-25390. doi:10.1021/acsnano.3c08869

BibTeX
@article{Liu2023,
  author = {Liu, Xinyu and Chen, Zhongxing and Bai, Jieyi and Li, Xin and Chen, Xin and Li, Zheng and Pan, Hongxian and Li, Siheng and Gao, Qingyi and Zhao, Nan and Chen, Aodong and Xu, Huilin and Wen, Yinuo and Du, Lan and Yang, Mei and Zhou, Xingtao and Huang, Jinhai},
  title = {Multifunctional Hydrogel Eye Drops for Synergistic Treatment of Ocular Inflammatory Disease},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {24},
  pages = {25377--25390},
  doi = {10.1021/acsnano.3c08869}
}
Kostenlos starten →